Table 2.
One-year relative survival (RS) expressed as percentages with 95% confidence interval (95%CI)
| Before CPP | During CPP | After CPP | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total | Non-CPP referred | CPP referred | ||||||||
| RS | (95%CI) | RS | (95%CI) | RS | (95%CI) | RS | (95%CI) | RS | (95%CI) | |
| CRC | 79.5 | (74.0;84.0) | 80.9 | (78.1;83.4) | 82.0 | (78.4;85.0) | 82.9 | (78.4;86.5) | 80.1 | (74.0;85.7) |
| Lung | 31.7 | (26.6;36.9) | 38.7 | (35.4;42.0) | 43.7 | (39.6;47.8) | 40.5 | (35.4;45.6) | 48.7 | (41.7;55.3) |
| Melanoma | 93.9 | (87.7;97.0) | 96.9 | (93.9;98.5) | 96.5 | (92.2;98.4) | 97.9 | (90.9;99.5) | 92.9 | (83.7;97.0) |
| Head & neck | 77.1 | (63.5;87.1) | 87.3 | (80.5;91.8) | 83.1 | (75.2;88.7) | 86.8 | (78.0;92.2) | 70.0 | (52.5;82.1) |
| Upper GI | 31.3 | (24.9;38.0) | 38.5 | (34.6;42.3) | 38.6 | (33.4;43.8) | 37.6 | (31.6;43.5) | a | |
| Gynaecological | 76.9 | (68.5;83.3) | 84.7 | (80.7;87.9) | 90.7 | (85.5;94.1) | 89.3 | (82.7;93.5) | 95.3 | (84.3;98.7) |
| Urinary system | 65.8 | (56.4;73.6) | 74.1 | (69.1;78.4) | 77.3 | (69.7;83.2) | 73.7 | (64.1;81.2) | a | |
| Total | 60.7 | (57.8;63.4) | 66.5 | (65.0;68.0) | 69.0 | (67.1;70.9) | 68.7 | (66.3;70.9) | 69.8 | (66.4;73.0) |
RS estimates are calculated using the complete approach and standardised using ICSS weights. Underlying mortality was accounted for using life tables. aCould not be computed due to a low number of cases